AU1261501A - Compositions and methods for intranasal delivery of active agents to the brain - Google Patents
Compositions and methods for intranasal delivery of active agents to the brainInfo
- Publication number
- AU1261501A AU1261501A AU12615/01A AU1261501A AU1261501A AU 1261501 A AU1261501 A AU 1261501A AU 12615/01 A AU12615/01 A AU 12615/01A AU 1261501 A AU1261501 A AU 1261501A AU 1261501 A AU1261501 A AU 1261501A
- Authority
- AU
- Australia
- Prior art keywords
- brain
- compositions
- methods
- active agents
- intranasal delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16876299P | 1999-12-06 | 1999-12-06 | |
US60168762 | 1999-12-06 | ||
US70366700A | 2000-11-02 | 2000-11-02 | |
US09703667 | 2000-11-02 | ||
PCT/CA2000/001311 WO2001041732A1 (en) | 1999-12-06 | 2000-11-03 | Compositions and methods for intranasal delivery of active agents to the brain |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1261501A true AU1261501A (en) | 2001-06-18 |
Family
ID=26864429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12615/01A Abandoned AU1261501A (en) | 1999-12-06 | 2000-11-03 | Compositions and methods for intranasal delivery of active agents to the brain |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1261501A (en) |
CA (1) | CA2325106A1 (en) |
WO (1) | WO2001041732A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
EP1392262A1 (en) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
EP1446102A1 (en) | 2001-11-21 | 2004-08-18 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
EP1625334B9 (en) | 2003-05-21 | 2012-07-25 | Alexza Pharmaceuticals, Inc. | Percussively ignited self-contained heating unit |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
DK1530965T3 (en) | 2003-11-11 | 2006-07-17 | Mattern Udo | Controlled release delivery system for nasal application |
US20060252738A1 (en) * | 2005-05-06 | 2006-11-09 | Phero Tech Inc. | Method for preparing and using water-based steroid pheromone compositions |
EP2056800B1 (en) | 2005-08-26 | 2015-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Therapy procedure for drug delivery for trigeminal pain |
DE602007012276D1 (en) | 2006-10-04 | 2011-03-10 | M & P Patent Ag | DISTRIBUTION SYSTEM WITH TAXED RELEASE FOR THE NASAL APPLICATION OF NEUROTRANSMITTERS |
ES2594867T3 (en) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
CN102652815B (en) * | 2012-05-09 | 2013-11-06 | 武汉市健恒生物科技有限责任公司 | Medicament composite for improving memory as well as preparation method and application thereof |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
CA2972975A1 (en) | 2015-01-07 | 2016-07-14 | Trigemina, Inc. | Magnesium-containing oxytocin formulations and methods of use |
US11813354B1 (en) * | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
CN114159448A (en) * | 2021-12-10 | 2022-03-11 | 深圳先进技术研究院 | Application of steroid substance in preparation of preparation for improving attention |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
DE3601923A1 (en) * | 1986-01-23 | 1987-07-30 | Behringwerke Ag | NASAL APPLICABLE MEDICINE, METHOD FOR THE PRODUCTION AND USE THEREOF |
IT1222395B (en) * | 1987-07-30 | 1990-09-05 | Pierrel Spa | PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION INCLUDING THE HORMONE GHRH, A COLINERGIC AGONIST AND / OR A BILE SALT |
WO1991007947A1 (en) * | 1989-12-05 | 1991-06-13 | Ramsey Foundation | Neurologic agents for nasal administration to the brain |
DE4218291A1 (en) * | 1992-06-03 | 1993-12-09 | Mattern Et Partner Pharmazeuti | Dosing spray for pernasal application |
WO1996000069A1 (en) * | 1994-06-23 | 1996-01-04 | The Procter & Gamble Company | Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration |
CA2260253A1 (en) * | 1996-07-23 | 1998-01-29 | Clive L. Jennings-White | Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
WO1998003641A1 (en) * | 1996-07-23 | 1998-01-29 | Crandall Wilson T | Transdermal transport of molecules |
EP1093348A4 (en) * | 1998-06-29 | 2003-07-16 | Pharmaceuticals Applic Asociat | Methods and transdermal compositions for pain relief |
-
2000
- 2000-11-03 AU AU12615/01A patent/AU1261501A/en not_active Abandoned
- 2000-11-03 CA CA 2325106 patent/CA2325106A1/en not_active Abandoned
- 2000-11-03 WO PCT/CA2000/001311 patent/WO2001041732A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2325106A1 (en) | 2001-06-06 |
WO2001041732A1 (en) | 2001-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
AU1261501A (en) | Compositions and methods for intranasal delivery of active agents to the brain | |
AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
AU2002243277A1 (en) | Methods and compositions for encapsulating active agents | |
AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
AU5905400A (en) | Methods and compositions for delivery and retention of active agents to lymph nodes | |
AU4460900A (en) | Carrier patch for the delivery of agents to the skin | |
AU2093101A (en) | Compositions for efficient release of active ingredients | |
IL148933A0 (en) | Compositions and methods for tumor-targeted delivery of effector molecules | |
AU2609901A (en) | Antimicrobial compositions and methods of use | |
AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
AU2003229084A1 (en) | Methods and formulations for the delivery of pharmacologically active agents | |
IL142807A0 (en) | Controlled delivery of active agents | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
AU1969800A (en) | Combination of active agents | |
AU6056500A (en) | Process and composition for temporarily suppressing pain | |
AU7792900A (en) | Distribution of certifiers | |
EP1075184A4 (en) | Compositions and methods for active vaccination | |
AU2002316200A1 (en) | Compound and composition for delivering active agents | |
HUP0303178A3 (en) | Methods and compositions for reducing the taste of pharmaceutically active agents | |
AU5802800A (en) | Form of administration for applying in body orifices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |